College of Oriental Medicine, Dongshin University, Naju, Jeollanam-do, 58245, South Korea.
Department of Policy Development, National Institute of Korean Medicine Development, Junggu, Seoul, 04561, South Korea.
BMC Complement Med Ther. 2022 May 18;22(1):137. doi: 10.1186/s12906-022-03614-0.
Cancer-related incidence and mortality rates are rapidly increasing worldwide. However, no studies have examined the effect of cancer as a single factor on the use of traditional, complementary, and alternative medicine (T&CAM). We aimed to determine the effect of cancer occurrence on T&CAM utilization using Korea Health Panel (KHP) data.
We analyzed longitudinal data (49,380 observations) derived from 12,975 Korean adult participants with complete KHP data from 2011 to 2014 and 2016, and divided them into two groups based on cancer diagnosis. A panel multinomial logit model was used to assess whether the participants used T&CAM or conventional medicine or both in outpatient settings. Additionally, a negative binomial regression model was used to examine the effect of cancer on the number of outpatient visits for T&CAM.
In total, 25.54% of the study participants in the cancer group used T&CAM, which was higher than that in the non-cancer group (18.37%, p < 0.0001). A panel multinomial logistic regression analysis using KHP data showed that cancer occurrence was significantly more likely to be associated with 'Using both Korean medicine and conventional medicine' (Coef. = 0.80, p = 0.017) and 'Not using Korean medicine but using conventional medicine' (Coef. = 0.85, p = 0.008) than 'Not using Korean medicine and conventional medicine.' A panel negative binomial regression showed a significant effect of cancer on increasing the number of T&CAM outpatient visits (Coef. = 0.11, p = 0.040).
Our findings showed that cancer occurrence within an individual led to the simultaneous use of conventional medicine and T&CAM. In addition, the occurrence of cancer significantly increased the number of T&CAM outpatient visits among participants already using T&CAM. It was also found that T&CAM has been utilized more often by the most vulnerable people, such as medical beneficiaries and those with a low level of education.
癌症的发病率和死亡率在全球范围内迅速上升。然而,尚无研究探讨癌症作为单一因素对传统、补充和替代医学(T&CAM)的使用的影响。我们旨在使用韩国健康面板(KHP)数据确定癌症发生对 T&CAM 利用的影响。
我们分析了 2011 年至 2014 年和 2016 年期间来自 12975 名韩国成年参与者的完整 KHP 数据中得出的纵向数据(49380 次观察),并根据癌症诊断将他们分为两组。使用面板多项逻辑回归模型评估参与者在门诊环境中是否使用 T&CAM 或常规医学或两者兼用。此外,还使用负二项回归模型检验癌症对 T&CAM 门诊就诊次数的影响。
在癌症组中,共有 25.54%的研究参与者使用 T&CAM,高于非癌症组(18.37%,p<0.0001)。使用 KHP 数据的面板多项逻辑回归分析表明,癌症发生与“同时使用韩医学和常规医学”(Coef. = 0.80,p = 0.017)和“不使用韩医学但使用常规医学”(Coef. = 0.85,p = 0.008)的关联显著大于“不使用韩医学和常规医学”。面板负二项回归显示癌症对增加 T&CAM 门诊就诊次数有显著影响(Coef. = 0.11,p = 0.040)。
我们的研究结果表明,个体中癌症的发生导致常规医学和 T&CAM 的同时使用。此外,癌症的发生显著增加了已经使用 T&CAM 的参与者的 T&CAM 门诊就诊次数。还发现 T&CAM 更多地被最弱势群体,如医疗受益人和教育程度较低的人使用。